The FDA has begun soliciting feedback to inform the next version of the Prescription Drug User Fee Act. User fees remain ...

A new Massachusetts law may be the most far-reaching U.S. state legislation aimed at curtailing the influence of private equity in health care. It could serve as a model for other jurisdictions.

The need to suppress a patient’s immune system after the transplantation of allogeneic cells is associated with wide-ranging side effects. We report the outcomes of transplantation of ...

“Corporatization” of health care, a process predicted decades ago, now refers to the general trend throughout the industry toward higher levels of integrated control by consolidated profit-seeking ...

To the Editor: In the 2IQP trial, Kudva and colleagues (May 8 issue) 1 found that in adults with insulin-treated type 2 diabetes, automated insulin delivery (AID) led to a greater reduction in ...

The extreme reductions that the Trump administration is making at the vital, mission-driven Centers for Disease Control and Prevention amount to unilateral disarmament against health hazards.

Though infant mortality has continuously been targeted by health policy agendas, policies tend to place it in an individualistic and narrow frame, failing to consider and address its structural ...

Making it harder to qualify for and stay enrolled in Medicaid or subsidized ACA coverage, the 2025 budget reconciliation act represents the largest rollback of health insurance coverage in U.S. his ...

This Double Take video explores the link between certain strains of human papillomavirus and cancer and reviews the evidence ...

Understanding today’s corporatization of U.S. health care requires seeing it from a historical perspective, as a process that began with a change in the business model of care delivery in the 1920s.

A 71-year-old woman with systemic lupus erythematosus presented to the ophthalmology clinic for an annual screening examination for hydroxychloroquine-related toxic effects. She reported no vision ...

The rate of fatalities on U.S. roadways is much higher than those in many other high-income nations. The authors review evidence-based strategies for moving toward a future with no traffic deaths.